Sens. Hassan, Smith Urge Insulin Manufacturers to Fulfill Their Commitment to Lowering Insulin Costs
September 01, 2023
September 01, 2023
WASHINGTON, Sept. 1 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
U.S. Senators Maggie Hassan (D-NH) and Tina Smith (D-MN) pressed three major insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi, on increasing access to lower-cost insulin for Americans with diabetes. Earlier this year, the three manufacturers had announced that they would make some types of insulin available at $35 per month or less. This announcement followed the passage of the I . . .
U.S. Senators Maggie Hassan (D-NH) and Tina Smith (D-MN) pressed three major insulin manufacturers, Eli Lilly, Novo Nordisk, and Sanofi, on increasing access to lower-cost insulin for Americans with diabetes. Earlier this year, the three manufacturers had announced that they would make some types of insulin available at $35 per month or less. This announcement followed the passage of the I . . .